The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
IRAK4 Kinase Activity Is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness
Open accessAbstract
Interleukin-1 (IL-1) stimulation leads to the recruitment of interleukin-1 receptor-associated kinase (IRAK) to the IL-1 receptor, where IRAK is phosphorylated, ubiquitinated, and eventually degraded. Kinase-inactive mutant IRAK is still phosphorylated in response to IL-1 stimulation when it is transfected into IRAK-deficient cells, suggesting that there must be an IRAK kinase in the pathway. The fact that IRAK4, another IRAK family member necessary for the IL-1 pathway, is able to phosphorylate IRAK in vitro suggests that IRAK4 might be the IRAK kinase. However, we now found that the IRAK4 kinase-inactive mutant had the same ability as the wild-type IRAK4 in restoring IL-1-mediated signaling in human IRAK4-deficient cells, including NFkappaB-dependent reporter gene expression, the activation of NFkappaB and JNK, and endogenous IL-8 gene expression. These results strongly indicate that the kinase activity of human IRAK4 is not necessary for IL-1 signaling. Furthermore, we showed that the kinase activity of IRAK4 was not necessary for IL-1-induced IRAK phosphorylation, suggesting that IRAK phosphorylation can probably be achieved either by autophosphorylation or by trans-phosphorylation through IRAK4. In support of this, only the impairment of the kinase activity of both IRAK and IRAK4 efficiently abolished the IL-1 pathway, demonstrating that the kinase activity of IRAK and IRAK4 is redundant for IL-1-mediated signaling. Moreover, consistent with the fact that IRAK4 is a necessary component of the IL-1 pathway, we found that IRAK4 was required for the efficient recruitment of IRAK to the IL-1 receptor complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Particularly for IRAK4, its scaffolding role in Toll-like receptor (TLR) signalling around the myddosome is established165,172”
From PROTAC targeted protein degraders: the past is prologue (2022) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. J. (1997) · Nature · doi:10.1038/41131 · Cited by 6,137
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,622
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
Mercurio, F., Zhu, H., Murray, B. W., Shevchenko, A., Bennett, B. L., Li, J. W., Young, D. B., Barbosa, M. S., Mann, M., Manning, A. M., et al. (1997) · Science · doi:10.1126/science.278.5339.860 · Cited by 2,042
A family of human receptors structurally related to Drosophila Toll.
Rock, F., Hardiman, G., Timans, J., Kastelein, R., & Bazan, J. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.2.588 · Cited by 2,009
Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,814
TRAF6 is a signal transducer for interleukin-1
Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., & Goeddel, D. V. (1996) · Nature · doi:10.1038/383443a0 · Cited by 1,305
MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.
Wesche, H., Henzel, W., Shillinglaw, W., Li, S., & Cao, Z.-D. (1997) · Immunity · doi:10.1016/s1074-7613(00)80402-1 · Cited by 1,247
Ninomiya‐Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,187
Flagged first, then by citations
Research works printed but not linked: 2
- Chuang, 2000, Eur. Cytokine Netw., 11, 372
- Jiang, 2002, J. Biol. Chem.
Cited by
Sorted by citations
PROTAC targeted protein degraders: the past is prologue
Békés, M., Langley, D. R., & Crews, C. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00371-6 · Cited by 3,395
Regulation and Function of IKK and IKK-Related Kinases
Häcker, H., & Karin, M. (2006) · Science s STKE · doi:10.1126/stke.3572006re13 · Cited by 1,298
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4
Pålsson‐McDermott, E. M., & O'Neill, L. A. J. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01976.x · Cited by 1,254
Targeted protein degradation: mechanisms, strategies and application
Zhao, L., Zhao, J., Zhong, K., Tong, A., & Jia, D. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00966-4 · Cited by 1,035
Structure and Function of Toll Receptors and Their Ligands
Gay, N. J., & Gangloff, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060305.151318 · Cited by 690
Doyle, S., & O'Neill, L. A. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.010 · Cited by 594
Uematsu, S., Sato, S., Yamamoto, M., Hirotani, T., Kato, H., Takeshita, F., Matsuda, M., Coban, C., Ishii, K. J., Kawai, T., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042372 · Cited by 488
TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme
Verstrepen, L., Bekaert, T., Chau, T., Tavernier, J. H., Chariot, A., & Beyaert, R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8064-8 · Cited by 448
Ku, C., von Bernuth, H., Pïcard, C., Zhang, S., Chang, H., Yang, K., Chrabieh, M., Issekutz, A. C., Cunningham, C. K., Gallin, J. I., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070628 · Cited by 399
Self-citationThe interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling
Flannery, S. M., & Bowie, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.020 · Cited by 316
Plant and Animal Pathogen Recognition Receptors Signal through Non-RD Kinases
Dardick, C. D., & Ronald, P. C. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020002 · Cited by 282
A critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity
Kim, T. W., Staschke, K. A., Bulek, K., Yao, J., Peters, K. L., Oh, K., Vandenburg, Y. R., Xiao, H. Q., Wen, Q., Hamilton, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061825 · Cited by 276
Self-citationIRAK1: A critical signaling mediator of innate immunity
Gottipati, S., Rao, N. L., & Fung‐Leung, W. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.08.009 · Cited by 274
Toll‐like receptors – sentries in the B‐cell response
Bekeredjian-Ding, I., & Jego, G. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03173.x · Cited by 249
Conze, D. B., Wu, C.-J., Thomas, J. A., Landstrom, A., & Ashwell, J. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02098-07 · Cited by 237
Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
Carmody, R. J., & Chen, Y. H. (2007) · PubMed · Cited by 231
Understanding early TLR signaling through the Myddosome
Balka, K. R., & Nardo, D. D. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-096r · Cited by 201
Innate immune signals in atherosclerosis
Lundberg, A. M., & Hansson, G. K. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 200
Kawagoe, T., Sato, S., Jung, A., Yamamoto, M., Matsui, K., Kato, H., Uematsu, S., Takeuchi, O., & Akira, S. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061523 · Cited by 187
Rhyasen, G. W., & Starczynowski, D. T. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.513 · Cited by 175
Nardo, D. D., Balka, K. R., Gloria, Y. C., Rao, V. R., Latz, E., & Masters, S. L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003314 · Cited by 156
Signalling of Toll-Like Receptors
Brikos, C., & O'Neill, L. A. J. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72167-3_2 · Cited by 157
Lye, E., Mirtsos, C., Suzuki, N., Suzuki, S., & Yeh, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402666200 · Cited by 144
Targeting IRAK4 for Degradation with PROTACs
Nunes, J., McGonagle, G. A., Eden, J., Kiritharan, G., Touzet, M., Lewell, X., Emery, J., Eidam, H., Harling, J. D., & Anderson, N. A. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00219 · Cited by 134
Regulation of innate immune signaling by IRAK proteins
Pereira, M. C. A., & Gazzinelli, R. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133354 · Cited by 134
The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways
Pereira, M. C. A., Durso, D. F., Bryant, C. E., Kurt‐Jones, E. A., Silverman, N. S., Golenbock, D. T., & Gazzinelli, R. T. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111225 · Cited by 127
Huang, Y., Li, T., Sane, D. C., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410369200 · Cited by 123
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126
Yao, J., Kim, T. W., Qin, J., Jiang, Z., Qian, Y., Xiao, H. Q., Lu, Y., Wen, Q., Gulen, M. F., Sizemore, N., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609039200 · Cited by 117
Self-citationLu, T., Tian, L., Han, Y., Vogelbaum, M., & Stark, G. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700118104 · Cited by 113
Yu, Y., Ge, N., Xie, M., Sun, W., Burlingame, S. M., Pass, A. K., Nuchtern, J. G., Zhang, D., Fu, S., Schneider, M. D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802825200 · Cited by 112
Chaudhary, D., Robinson, S. D., & Romero, D. L. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5016044 · Cited by 109
Pellino Proteins: Novel Players in TLR and IL‐1R Signalling
Schauvliege, R., Janssens, S., & Beyaert, R. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00040.x · Cited by 100
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Bennett, J., & Starczynowski, D. T. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000693 · Cited by 100
Winkler, A. R., Sun, W., De, S., Jiao, A., Sharif, M., Symanowicz, P. T., Athale, S., Shin, J. H., Wang, J., Jacobson, B. A., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41953 · Cited by 93
TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent
Qin, J., Yao, J., Cui, G., Xiao, H. Q., Kim, T. W., Frączek, J., Wightman, P. D., Sato, S., Akira, S., Puel, A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512908200 · Cited by 93
Self-citationXiong, Y., Qiu, F., Piao, W., Song, C. H., Wahl, L. M., & Medvedev, A. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182873 · Cited by 93
Koziczak‐Holbro, M., Joyce, C., Glück, A., Kinzel, B., Müller, M., Tschopp, C., Mathison, J. C., Davis, C. N., & Gram, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700548200 · Cited by 92
Wan, Y., Xiao, H. Q., Affolter, J. T., Kim, T. W., Bulek, K., Chaudhuri, S., Carlson, D., Hamilton, T. A., Mazumder, B., Stark, G. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807822200 · Cited by 89
Self-citationTAK1 mediates convergence of cellular signals for death and survival
Aashaq, S., Batool, A., & Andrabi, K. I. (2018) · APOPTOSIS · doi:10.1007/s10495-018-1490-7 · Cited by 86
Maitra, U., Gan, L., Chang, S., & Li, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003300 · Cited by 82
Sun, J., Li, N., Oh, K., Dutta, B., Vayttaden, S. J., Lin, B., Ebert, T. S., Nardo, D. D., Davis, J., Bagirzadeh, R., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aab2191 · Cited by 81
Ntoufa, S., Vilia, M. G., Σταματόπουλος, Κ., Ghia, P., & Muzio, M. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.07.001 · Cited by 84
Armaroli, G., Verweyen, E. L., Pretzer, C., Kessel, K., Hirono, K., Ichida, F., Okabe, M., Cabral, D. A., Foell, D., Brown, K. L., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40784 · Cited by 78
IRAK4 in TLR/IL‐1R signaling: Possible clinical applications
Li, X. (2008) · European Journal of Immunology · doi:10.1002/eji.200838161 · Cited by 77
Self-citationRegulation of IRAK-4 kinase activity via autophosphorylation within its activation loop
Cheng, H., Addona, T. A., Keshishian, H., Dahlstrand, E. N., Lu, C., Dorsch, M., Li, Z., Wang, A., Ocain, T. D., Li, P., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.068 · Cited by 76
Ferrao, R., Li, J., Bergamin, E., & Wu, H. (2012) · Science Signaling · doi:10.1126/scisignal.2003124 · Cited by 75
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma
Fultang, L., Gamble, L. D., Gneo, L., Berry, A. M., Egan, S. A., de Bie, F. J., Yogev, O., Eden, G. L., Booth, S., Brownhill, S. C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2139 · Cited by 70
IRAK-4 – a shared NF-κB activator in innate and acquired immunity
Suzuki, N., & Saito, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.003 · Cited by 67
Cushing, L., Stochaj, W. R., Siegel, M. M., Czerwiński, R., Dower, K., Wright, Q. G., Hirschfield, M., Casanova, J., Pïcard, C., Puel, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544809 · Cited by 64
Self-citationSong, K. W., Talamás, F. X., Suttmann, R. T., Olson, P. S., Barnett, J. W., Lee, S. W., Thompson, K., Jin, S., Hekmat-Nejad, M., Cai, T. Z., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.012 · Cited by 61
Chiang, E. Y., Yu, X., & Grogan, J. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002821 · Cited by 60
Frączek, J., Kim, T. W., Xiao, H., Yao, J., Wen, Q., Li, Y.-L., Casanova, J., Pryjma, J., & Li, X.-X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804779200 · Cited by 60
Self-citationMedvedev, A. E., Thomas, K., Awomoyi, A. A., Kuhns, D. B., Gallin, J. I., Li, X., & Vogel, S. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6587 · Cited by 49
Self-citationAutosomal recessive Interleukin-1 receptor-associated kinase 4 deficiency in fourth-degree relatives
Cárdenes, M., von Bernuth, H., García-Saavedra, A., Santiago, E., Puel, A., Ku, C., Emile, J., Pïcard, C., Casanova, J., Colino, E., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.012 · Cited by 49
Self-citationRokosz, L. L., Beasley, J. R., Carroll, C. D., Lin, T. H., Zhao, J., Appell, K. C., & Webb, M. L. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.883 · Cited by 49
De, S., Karim, F., Kiessu, E., Cushing, L., Lin, L.-L., Ghandil, P., Hoarau, C., Casanova, J., Puel, A., & Rao, V. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003831 · Cited by 46
Self-citationToll-like receptors (TLRs) and immune disorders
Akashi‐Takamura, S., & Miyake, K. (2006) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0477-4 · Cited by 45
Septicemia without Sepsis: Inherited Disorders of Nuclear Factor-kB-Mediated Inflammation
von Bernuth, H., Puel, A., Ku, C., Yang, K., Bustamante, J. C., Chang, H., Pïcard, C., & Casanova, J. (2005) · Clinical Infectious Diseases · doi:10.1086/431994 · Cited by 45
Self-citationTranscriptome Sequencing of Gene Expression in the Brain of the HIV-1 Transgenic Rat
Li, M. D., Cao, J., Wang, S., Wang, J., Sarkar, S., Vigorito, M., Ma, J. Z., & Chang, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059582 · Cited by 44
Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery
Xi, J., Zhang, R., Chen, K., Yao, L., Li, M., Jiang, R., Li, X., & Fan, L. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105848 · Cited by 45
Self-citationInherited human IRAK-4 deficiency: an update
Pïcard, C., von Bernuth, H., Ku, C., Yang, K., Puel, A., & Casanova, J. (2007) · Immunologic Research · doi:10.1007/s12026-007-0006-2 · Cited by 43
Self-citationIdentification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4
Tumey, L. N., Boschelli, D. H., Bhagirath, N., Shim, J., Murphy, E. A., Goodwin, D., Bennett, E. M., Wang, M., Lin, L., Press, B., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.056 · Cited by 40
Li, Y.-W., Mo, X., Zhou, L., Li, X., Dan, X., Luo, X., & Li, A. (2014) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2014.02.019 · Cited by 40
Self-citationKar, S., Ukil, A., & Das, P. K. (2010) · European Journal of Immunology · doi:10.1002/eji.201040533 · Cited by 39
Functional assessment of the mutational effects of human IRAK4 and MyD88 genes
Yamamoto, T. S., Tsutsumi, N., Tochio, H., Ohnishi, H., Kubota, K., Kato, Z., Shirakawa, M., & Kondo, N. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.11.008 · Cited by 32
Kubo-Murai, M., Hazeki, K., Nigorikawa, K., Omoto, T., Inoue, N., & Hazeki, O. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm234 · Cited by 33
Pathophysiology of interleukin-1 receptor-associated kinase-M: implications in refractory state
López‐Collazo, E., Fuentes‐Prior, P., Arnalich, F., & del Fresno, C. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000224817.35105.7d · Cited by 31
Liu, W., & Shou, C. (2011) · Biological Research · doi:10.4067/s0716-97602011000400011 · Cited by 25
Zou, P., Huang, X. N., Yao, C.-L., Sun, Q. X., Li, Y., Zhu, Q., Yu, Z. X., & Fan, Z. J. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.12.019 · Cited by 24
Tang, X., Huang, B., Zhang, L., Li, L., & Zhang, G. (2017) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2017.02.004 · Cited by 23
Cai, H. X., Zhang, T., & Yuanjia, H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118055 · Cited by 26
Han, X., Gao, F., Lu, M., Liu, Z., Wang, M., Ke, X., Yi, M., & Cao, J. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.12.041 · Cited by 22
Mechanisms underlying impaired spermatogenic function in orchitis induced by busulfan
Zhao, L., Zhao, J., Dong, Z., Xu, S., & Wang, D. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.11.002 · Cited by 17
Emerging trends in IRAK-4 kinase research
Yadav, H. K., & Shirumalla, R. K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08438-w · Cited by 15
Solving the IRAK-4 Enigma: Application of Kinase-Dead Knock-In Mice
Koziczak‐Holbro, M., Joyce, C., Glück, A., Kinzel, B., Müller, M. M., & Gram, H. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2007_071 · Cited by 12
Cui, Y., Jiang, L., Xing, R., Wang, Z., Wang, Z., Shao, Y., Zhang, W., Zhao, X., & Li, C. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.08.006 · Cited by 10
Central IRAK-4 kinase inhibition for the treatment of pain following nerve injury in rats
Pletinckx, K., Krings, D., Welbers, A., Rider, D. A., & Dunkern, T. R. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.035 · Cited by 10
Cellular trafficking of the IL-1RI-associated kinase-1 requires intact kinase activity
Böl, G., Jurrmann, N., & Brigelius‐Flohé, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.121 · Cited by 10
MyD88-induced downregulation of IRAK-4 and its structural requirements
Hatao, F., Yamamoto, M., Muroi, M., Kaminishi, M., & Tanamoto, K. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00425.x · Cited by 9
New insights into the post-translational modification of Toll-like receptor signaling molecules
Dunne, A., & O'Neill, L. A. J. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110060701 · Cited by 8
Britan, A., Cusin, I., Hinard, V., Mottin, L., Pasche, E., Gobeill, J., de Laval, V. R., Gleizes, A., Teixeira, D., Michel, P.-A., et al. (2018) · Database · doi:10.1093/database/bay129 · Cited by 11
Peterson, J., Sivars, K. B., Bianco, A., & Röper, K. (2023) · Development · doi:10.1242/dev.201893 · Cited by 7
Hekmat-Nejad, M., Cai, T. Z., & Swinney, D. C. (2010) · Biochemistry · doi:10.1021/bi901609m · Cited by 8
Pattern recognition receptors: an update
Goutagny, N., & Fitzgerald, K. A. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.4.569 · Cited by 8
Vogt, L. M., Boekschoten, M. V., de Groot, P. J., Faas, M. M., & de Vos, P. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.08.011 · Cited by 8
Cloning and Characterization of DULP, a Novel Ubiquitin-Like Molecule from Human Dendritic Cells
Liu, G.-Y., Liu, S., Li, P., Tang, L. F. P., Han, Y., An, H., Li, J.-Y., Dai, X., Li, N., Cao, X., et al. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.4 · Cited by 6
Peng, Y., Peng, C.-T., Lin, Y., Lin, G., Huang, S., Chen, S., Sytwu, H., & Cheng, C.-P. (2020) · Mediators of Inflammation · doi:10.1155/2020/1237281 · Cited by 4
Han, R., Wang, J.-L., Chen, H., Luo, X., Li, A., Dan, X., & Li, Y. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.09.011 · Cited by 3
PROteolysis TArgetting Chimeras (PROTACs) Strategy Applied to Kinases: Recent Advances
Feral, A., Laconde, G., Amblard, M., & Masurier, N. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000148 · Cited by 3
Chen, Y., Sun, D., Yang, R., Lim, J., Sondey, C., Presland, J. P., Rakhilina, L., Addona, G. H., Kariv, I., & Chen, H. (2021) · SLAS DISCOVERY · doi:10.1177/24725552211021074 · Cited by 2
The Latest Advancements of the PROTACs Based on CRBN E3 Ligase for Cancer Treatment
Stadnichenko, V. O., Borysko, P., & Tolstanova, G. M. (2025) · Current Pharmacology Reports · doi:10.1007/s40495-025-00409-y · Cited by 2
Proinflammatory Chemical Signaling: Cytokines
Nagamoto‐Combs, K., & Combs, C. K. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_6 · Cited by 2
Synthesis and in vitro characterization of novel IRAK-4 inhibitor compounds
Shrivastava, D., Gupta, L. K., Yerrapureddy, A., & Nune, S. S. K. (2026) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2026.2620804 · Cited by 1
Dickkopf1 is a novel endogenous ligand for priming NLRP3 inflammasome in macrophages via TLR4
Aung, T., Song, S., Kasongo, J., Harada, H., Zhang, S., Henegariu, O., & Chae, W. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkaf367 · Cited by 1
Stimulated protein degradation to promote mitochondrial function and neuronal survival
Chandrasekhar, S., McMinimy, R. A., Manford, A. G., Wehri, E., Gee, C. L., Miller, C., Bingol, B., Kuriyan, J., Schaletzky, J., & Rapé, M. (2026) · Science · doi:10.1126/science.aed2525 · Cited by 1
Life-Saving Degeneracy in the Human Immune System
Brodin, P. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.02.018 · Cited by 1
IRAK-4: A key kinase involved in toll-like receptor signaling and resistance to bacterial infection
Medvedev, A. E., Kuhns, D. B., Gallin, J. I., & Vogel, S. N. (2006) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7441-1_9 · Cited by 1
Toll‐Like Receptors in Atherosclerosis
Yan, Z.-Q., Edfeldt, K., & Lundberg, A. M. (2010) · Atherosclerosis · doi:10.1002/9783527629589.ch5
Bäckström, E. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Metadata
- Authors
- Qin, J., Jiang, Z., Qian, Y., Casanova, J.-L., & Li, X.
- Affiliations
- Cleveland State University (US)
- Cleveland Clinic (US)
- Inserm (FR)
- Corresponding author
- Li, Xiaoxia
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 279
- Issue
- 25
- Pages
- 26748-26753
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1964985092
- Cited by
- 110
- References
- 27
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 8 · 2017: 2 · 2016: 4 · 2015: 1 · 2014: 6 · 2013: 2 · 2012: 1
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM 60020, R01GM060020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- IRAK4, IRAK, IL-1 signaling, IL-1 receptor, kinase redundancy, transphosphorylation, autophosphorylation, NF-κB activation, JNK activation, IL-8 expression
- MeSH terms
- Cell Line, Dose-Response Relationship, Drug, Enzyme Activation, Fibroblasts, Genetic Complementation Test, Humans, Interleukin-1, Luciferases, Models, Biological, Mutation, Phosphorylation, Plasmids, Precipitin Tests, Time Factors, Transfection, Blotting, Northern, Blotting, Western, Interleukin-8, NF-kappa B, Receptors, Interleukin-1, Phosphotransferases (Alcohol Group Acceptor), Genes, Reporter, E-Selectin, Mitogen-Activated Protein Kinase Kinases, Ubiquitin, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Interleukin-1 Receptor-Associated Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review